Medindia
Medindia LOGIN REGISTER
Advertisement

Pharmacy Directors are Most Convinced to Reimburse Multiple Sclerosis Drugs Supported by Data Showing Significant Reductions in Relapses

Thursday, June 24, 2010 Corporate News
Advertisement
Majority of Surveyed Pharmacy Directors Expect to Look to Clinical Trial Endpoints When Evaluating the Relative Efficacy of MS Therapies, According to a New Report from HealthLeaders-InterStudy and Fingertip Formulary
Advertisement

For more information, contact:

Lisa Osgood

Elizabeth Marshall

HealthLeaders-InterStudy

Decision Resources, Inc-

781-296-2606

781-296-2563

[email protected]

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close